Revance Therapeutics
RVNC
3,37 €
Share price
0.00%
Change (1 day)
-19.81%
Change (1 year)
Categories
Revance Therapeutics (RVNC) - Total debt
Total debt on the balance sheet as of September 2024 : €0.44 Billion
According to Revance Therapeutics's latest financial reports the company's total debt is €0.44 Billion. A company’s total debt is the sum of all current and non-current debts.
Revance Therapeutics - Total debt on balance sheet (from 2012 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | €0.43 B | 10.94% |
| 2022-12-31 | €0.39 B | 36.15% |
| 2021-12-31 | €0.28 B | 66.16% |
| 2020-12-31 | €0.17 B | 558.42% |
| 2019-12-31 | €26.19 M | |
| 2018-12-31 | N/A | -100% |
| 2017-12-31 | €1.56 M | -69.31% |
| 2016-12-31 | €5.08 M | -34.46% |
| 2015-12-31 | €7.75 M | 166.48% |
| 2014-12-31 | €2.91 M | -84.23% |
| 2013-12-31 | €18.45 M | -77.06% |
| 2012-12-31 | €80.47 M | 51.49% |
| 2011-12-31 | €53.12 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 | €0.17 M | -99.96% | 🇺🇸 USA |
 | €33.80 B | 7,477.67% | 🇺🇸 USA |
 | €6.11 B | 1,271.46% | 🇺🇸 USA |